Procept Biorobotics Corp

General ticker "PRCT" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $4.8B

Procept Biorobotics Corp follows the US Stock Market performance with the rate: 60.0%.

Estimated limits based on current volatility of 2.4%: low 79.54$, high 83.48$

Factors to consider:

  • Current price 53.4% above estimated high
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [24.98$, 52.91$]
  • 2024-12-30 to 2025-12-30 estimated range: [21.21$, 46.38$]

Financial Metrics affecting the PRCT estimates:

  • Negative: Non-GAAP EPS, $ of -2.24 <= 0.10
  • Negative: Operating profit margin, % of -44.49 <= 1.03
  • Negative: Operating cash flow per share per price, % of -5.46 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85

Similar symbols

Short-term PRCT quotes

Long-term PRCT plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $34.47MM $75.01MM $136.19MM
Operating Expenses $88.64MM $155.74MM $245.36MM
Operating Income $-54.16MM $-80.72MM $-109.17MM
Non-Operating Income $-5.69MM $-6.43MM $3.27MM
Interest Expense $5.81MM $5.18MM $4.00MM
R&D Expense $18.99MM $28.98MM $48.45MM
Income(Loss) $-59.85MM $-87.15MM $-105.90MM
Profit(Loss) $-59.85MM $-87.15MM $-105.90MM
Stockholders Equity $267.09MM $197.07MM $280.75MM
Inventory $13.15MM $28.54MM $39.76MM
Assets $337.02MM $309.33MM $404.72MM
Operating Cash Flow $-57.33MM $-80.38MM $-108.00MM
Capital expenditure $0.59MM $2.65MM $25.21MM
Investing Cash Flow $-0.59MM $-2.65MM $-25.21MM
Financing Cash Flow $262.12MM $3.61MM $167.79MM
Earnings Per Share* $-1.43 $-2.11 $-2.24

* EPS are Split Adjusted, recent splits may be reflected with a delay.